Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185

Detalles Bibliográficos
Autores principales: Prada, Patricia O., Ropelle, Eduardo R., Mourão, Rosa H., de Souza, Claudio T., Pauli, Jose R., Cintra, Dennys E., Schenka, André, Rocco, Silvana A., Rittner, Roberto, Franchini, Kleber G., Vassallo, José, Velloso, Lício A., Carvalheira, José B., Saad, Mario J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Statement of Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482084/
https://www.ncbi.nlm.nih.gov/pubmed/28450418
http://dx.doi.org/10.2337/db17-rt07a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482084/
https://www.ncbi.nlm.nih.gov/pubmed/28450418
http://dx.doi.org/10.2337/db17-rt07a

Ejemplares similares